Regencell Bioscience Holdings Market Cap 2020-2023 | RGC

Regencell Bioscience Holdings market cap as of November 14, 2024 is $0.08B.

Regencell Bioscience Holdings market cap history and chart from 2020 to 2023. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding.

Regencell Bioscience Holdings Market Cap 2020-2023 | RGC

Regencell Bioscience Holdings market cap history and chart from 2020 to 2023. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$160.6B
Vertex Pharmaceuticals (VRTX)$126.2B
Bristol Myers Squibb (BMY)$119.7B
Gilead Sciences (GILD)$117.5B
Regeneron Pharmaceuticals (REGN)$90.2B
CSL (CSLLY)$90B
GSK (GSK)$73.6B
Argenex SE (ARGX)$35.5B
Alnylam Pharmaceuticals (ALNY)$34.7B
BioNTech SE (BNTX)$25.5B
Biogen (BIIB)$24.5B
Illumina (ILMN)$23.4B
BeiGene (BGNE)$18.9B
Moderna (MRNA)$16.7B
Incyte (INCY)$15.5B
Genmab (GMAB)$14.9B
BioMarin Pharmaceutical (BMRN)$12.6B
Insmed (INSM)$12.5B
Vaxcyte (PCVX)$12.4B
Bio-Techne Corp (TECH)$11.8B
Sarepta Therapeutics (SRPT)$10.9B
Exelixis (EXEL)$10.2B
Revolution Medicines (RVMD)$10B
QIAGEN (QGEN)$9.9B
Intra-Cellular Therapies (ITCI)$9.4B
Bio-Rad Laboratories (BIO.B)$9.4B
Exact Sciences (EXAS)$9.3B
Roivant Sciences (ROIV)$8.6B
Repligen (RGEN)$8.3B
Ascendis Pharma (ASND)$7.7B